CDx Diagnostics Revenue and Competitors

Suffern, NY USA

Location

N/A

Total Funding

3D

Industry

Estimated Revenue & Valuation

  • CDx Diagnostics's estimated annual revenue is currently $29.4M per year.(i)
  • CDx Diagnostics's estimated revenue per employee is $187,000

Employee Data

  • CDx Diagnostics has 157 Employees.(i)
  • CDx Diagnostics grew their employee count by -5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.8M5079%N/AN/A
#2
$0.4M5-81%N/AN/A
#3
$1.1M11-31%N/AN/A
#4
$3.3M2840%N/AN/A
#5
$1.4M14N/AN/AN/A
#6
$0M2-60%$13.8MN/A
#7
$1.7M1731%N/AN/A
#8
$8.9M60-13%$44.9MN/A
#9
$10.9M71-8%N/AN/A
#10
$43.6M233N/AN/AN/A
Add Company

CDx Diagnostics® is the world's leader in the detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. Our tests are primarily used to help prevent cancer before it can start by identifying still-harmless dysplasias (precancers),and are also used to identify early stage cancers when they can be most easily cured. Clinicians use CDx® patented brush biopsy instruments to non-invasively collect a broad, full thickness tissue specimen of a suspect lesion. This unique tissue specimen is then subjected to specialized, computer-assisted laboratory analysis. These life saving tests are nationally available to gastroenterologists, otolaryngologists, oral surgeons, periodontists, and dentists. CDx Diagnostics® includes tests developed and provided by CDx Laboratories, Inc. Oral Cancer Prevention International, Inc. and its US and international laboratory affiliates.

keywords:N/A

N/A

Total Funding

157

Number of Employees

$29.4M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$49M16527%N/A
#2
$44.9M180-4%N/A
#3
$63.9M2154%N/A
#4
$91.8M408-26%N/A
#5
$184M7649%N/A